Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.
Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.